Polypills make a difference in CVD

Bundling CVD medications into a single pill significantly improves patient adherence, show results from three trials.

Around 80% of patients at high risk of CVD randomised to a polypill were still taking their medication regularly a year later, compared with 50% of those randomised to usual care, data from five countries including Australia reveals.

The trials involved 3,100 patients